Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Prostate"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 379520

Starter badań:

Tytuł:
The use of statins is related to a lower PSA level after endoscopic enucleation of the prostate with holmium laser (HoLEP) for the treatment of BPH.
Autorzy:
Suartz CV; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil. caio.v_.; Divisão de Clínica Urológica, Hospital das Clínicas da Universidade de São Paulo, Avenida Dr. Éneas de Carvalho Aguiar, 255-Sala 710F, 7º Andar, São Paulo, SP, CEP 05403-000, Brasil. caio.v_.
Braz NDSF; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
Dos Anjos GC; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
Dos Reis ST; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
Nahas WC; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
Antunes AA; Division of Urology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 Aug; Vol. 41 (8), pp. 2149-2154. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Hyperplasia*/surgery
Prostatic Hyperplasia*/complications
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Lasers, Solid-State*/therapeutic use
Laser Therapy*/methods
Transurethral Resection of Prostate*/methods
Male ; Adult ; Humans ; Prostate/surgery ; Prostate-Specific Antigen ; Retrospective Studies ; Holmium ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of surgical procedures for benign prostatic hyperplasia of medium-volume prostates: evaluation of the causes of rehospitalization from the French National Hospital Database (PMSI-MCO).
Autorzy:
Behr A; Service d'Urologie CHRU Nancy, Site Brabois, 54000, Nancy, France. .
Salleron J; Département de Biostatistiques, Institut de Cancérologie de Lorraine, 54519, Vandoeuvre-les-Nancy Cedex, France.
Mazeaud C; Service d'Urologie CHRU Nancy, Site Brabois, 54000, Nancy, France.
Larose C; Service d'Urologie CHRU Nancy, Site Brabois, 54000, Nancy, France.
Dagry A; Real Consulting Data, 92120, Montrouge, France.
Balkau B; INSERM U1018, Epidémiologie Clinique, CESP, 94807, Villejuif, France.
Hubert J; Service d'Urologie CHRU Nancy, Site Brabois, 54000, Nancy, France.
Eschwège P; Service d'Urologie CHRU Nancy, Site Brabois, 54000, Nancy, France.; CNRS UMR 7039, Unité de Biologie des Tumeurs, CRAN, 54511, Vandoeuvre-les-Nancy, France.
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 Sep; Vol. 41 (9), pp. 2481-2488. Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Hyperplasia*/surgery
Prostatic Hyperplasia*/complications
Transurethral Resection of Prostate*/adverse effects
Transurethral Resection of Prostate*/methods
Laser Therapy*/methods
Lasers, Solid-State*/therapeutic use
Male ; Humans ; Prostate/surgery ; Patient Readmission ; Treatment Outcome ; Hospitals
Czasopismo naukowe
Szczegóły
Tytuł:
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.
Autorzy:
Wang M; Department of Urology, Wayne State University, Detroit, Michigan, USA.
Lange A; Department of Urology, Wayne State University, Detroit, Michigan, USA.
Perlman D; Department of Urology, Wayne State University, Detroit, Michigan, USA.
Qi J; University of Michigan Medical School, Ann Arbor, Michigan, USA.
George AK; University of Michigan Medical School, Ann Arbor, Michigan, USA.
Ferrante S; University of Michigan Medical School, Ann Arbor, Michigan, USA.
Semerjian A; IHA Urology, St. Joseph Mercy Hospital, Ann Arbor, Michigan, USA.
Sarle R; Department of Urology, Sparrow Point Hospitals, Lansing, Michigan, USA.
Cher ML; Department of Urology, Wayne State University, Detroit, Michigan, USA.
Ginsburg KB; Department of Urology, Wayne State University, Detroit, Michigan, USA.
Pokaż więcej
Corporate Authors:
Michigan Urological Surgery Improvement Collaborative; University of Michigan Medical School, Ann Arbor, Michigan, USA.
Źródło:
The Prostate [Prostate] 2023 Sep; Vol. 83 (12), pp. 1141-1149. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*/diagnostic imaging
Prostate*/pathology
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Prostate-Specific Antigen ; Retrospective Studies ; Watchful Waiting/methods ; Image-Guided Biopsy/methods ; Biopsy ; Magnetic Resonance Imaging/methods ; Neoplasm Grading
Czasopismo naukowe
Szczegóły
Tytuł:
The role of tumor density in predicting significant cancer on targeted biopsy of the prostate.
Autorzy:
Erlich G; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Savin Z; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Fahoum I; Department of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Barnes S; Department of Radiology, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Dahan E; Department of Emergency Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Bar-Yosef Y; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Yossepowitch O; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Keren-Paz G; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Mano R; Department of Urology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel. Electronic address: .
Pokaż więcej
Źródło:
Urologic oncology [Urol Oncol] 2023 Jul; Vol. 41 (7), pp. 323.e9-323.e15. Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/diagnostic imaging
Prostate*/pathology
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Prostate-Specific Antigen ; Magnetic Resonance Imaging/methods ; Retrospective Studies ; Image-Guided Biopsy/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Prognostic role of early prostate specific antigen changes after [ Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer: A meta-analysis.
Autorzy:
Giovanella L; Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland.
Garo ML; Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Research Unit of Cardiac Surgery, Department of Cardiovascular Surgery, Università Campus Bio-Medico, Rome, Italy.
Cuzzocrea M; Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Paone G; Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Herrmann K; Clinic for Nuclear Medicine, Essen University Hospital, Essen, Germany.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2023 Sep; Vol. 53 (9), pp. e14014. Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Prostatic Neoplasms, Castration-Resistant*/chemically induced
Male ; Humans ; Aged ; Prognosis ; Treatment Outcome ; Prostate/pathology ; Dipeptides/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Prostate health index (PHI) as an accurate prostate cancer predictor.
Autorzy:
Yáñez-Castillo YM; Department of Urology, San Cecilio University Hospital, Granada, Spain.
Melgarejo-Segura MT; Department of Urology, San Cecilio University Hospital, Granada, Spain.
Funes-Padilla C; Department of Urology, San Cecilio University Hospital, Granada, Spain.
Folgueral-Corral ME; Department of Urology, San Cecilio University Hospital, Granada, Spain.
García-Larios JV; Department of Clinical Analysis, San Cecilio University Hospital, Granada, Spain.
Arrabal-Polo MA; Department of Urology, San Cecilio University Hospital, Granada, Spain. .
De Haro Muñoz T; Department of Clinical Analysis, San Cecilio University Hospital, Granada, Spain.; IBS Institute, Granada, Spain.
Arrabal-Martín M; Department of Urology, San Cecilio University Hospital, Granada, Spain.; IBS Institute, Granada, Spain.
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Sep; Vol. 149 (11), pp. 9329-9335. Date of Electronic Publication: 2023 May 19.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Male ; Humans ; Prostate/pathology ; ROC Curve ; Prospective Studies ; Biopsy
Czasopismo naukowe
Szczegóły
Tytuł:
Same-day discharge for endoscopic enucleation of the prostate: a systematic review and meta-analysis.
Autorzy:
Diana P; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain. .; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy. .; Department of Urology, Hospitales Universitarios San Roque, Las Palmas de Gran Canaria, Spain. .; GUA Gabinete de Urología y Andrología, Las Palmas de Gran Canaria, Spain. .
Baboudjian M; Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France.; Department of Urology and Renal Transplantation, La Conception University Hospital, Aix-Marseille University, APHM, Marseille, France.
Saita A; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.
Uleri A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.
Gallioli A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.
Casale P; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.
Buffi N; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.
Pradere B; Department of Urology, La Croix du Sud Hospital, 31130, Quint Fonsegrives, France.
Misrai V; Department of Urology, Clinique Pasteur, Toulouse, France.
Gondran-Tellier B; Department of Urology and Renal Transplantation, La Conception University Hospital, Aix-Marseille University, APHM, Marseille, France.
Boissier R; Department of Urology and Renal Transplantation, La Conception University Hospital, Aix-Marseille University, APHM, Marseille, France.
Schwartzmann I; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.
Breda A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.
Del Dago PJ; Department of Urology, Hospitales Universitarios San Roque, Las Palmas de Gran Canaria, Spain.; GUA Gabinete de Urología y Andrología, Las Palmas de Gran Canaria, Spain.
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 Aug; Vol. 41 (8), pp. 2099-2106. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Prostatic Hyperplasia*/surgery
Transurethral Resection of Prostate*/methods
Male ; Humans ; Prostate/surgery ; Patient Discharge ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer.
Autorzy:
Fan J; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China; Department of Urology, Baoji Central Hospital, Baoji, P.R. China.
Liang H; Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Gu Y; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Jiang Z; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Jiang F; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Wang Y; Department of Urology, Baoji Central Hospital, Baoji, P.R. China.
He D; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Wu K; Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China. Electronic address: kaijie_.
Pokaż więcej
Źródło:
Urologic oncology [Urol Oncol] 2023 Aug; Vol. 41 (8), pp. 354.e1-354.e9. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate-Specific Antigen*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/surgery
Male ; Humans ; Neoadjuvant Therapy ; Ki-67 Antigen ; Prostate/surgery ; Prostate/pathology ; Prostatectomy
Czasopismo naukowe
Szczegóły
Tytuł:
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
Autorzy:
Pereira V; Urology Section, Durham VA Medical Center, Durham, North Carolina, USA.
Oyekunle T; Urology Section, Durham VA Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Janes J; Urology Section, Durham VA Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Amling CJ; Division of Urology, Oregon Health Sciences University, Portland, Oregon, USA.
Aronson WJ; Department of Surgery, Urology Section, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA.; Department of Urology, UCLA School of Medicine, Los Angeles, California, USA.
Cooperberg MR; Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
Kane CJ; Urology Department, University of California San Diego Health System, San Diego, California, USA.
Terris MK; Section of Urology, Veterans Affairs Health Care System, Augusta, Georgia, USA.; Section of Urology, Medical College of Georgia, Augusta, Georgia, USA.
Klaassen Z; Section of Urology, Veterans Affairs Health Care System, Augusta, Georgia, USA.; Section of Urology, Medical College of Georgia, Augusta, Georgia, USA.
Freedland SJ; Urology Section, Durham VA Medical Center, Durham, North Carolina, USA.; Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vidal AC; Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA.
Csizmadi I; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
The Prostate [Prostate] 2023 Aug; Vol. 83 (11), pp. 1011-1019. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/surgery
Prostate*/pathology
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Prostatectomy/methods ; Biopsy ; Prostate-Specific Antigen ; Delivery of Health Care
Czasopismo naukowe
Szczegóły
Tytuł:
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer.
Autorzy:
Esen B; Department of Urology, School of Medicine, Koç University, Istanbul, Turkey. Electronic address: .
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.
Bavbek S; Department of Medical Oncology, VKF American Hospital, Istanbul, Turkey.
Kordan Y; Department of Urology, School of Medicine, Koç University, Istanbul, Turkey.
Tilki D; Department of Urology, School of Medicine, Koç University, Istanbul, Turkey; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Esen T; Department of Urology, School of Medicine, Koç University, Istanbul, Turkey.
Pokaż więcej
Źródło:
European urology focus [Eur Urol Focus] 2023 Jul; Vol. 9 (4), pp. 596-605. Date of Electronic Publication: 2023 Feb 25.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*/pathology
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/drug therapy
Male ; Humans ; Positron-Emission Tomography/methods ; Prostate-Specific Antigen/metabolism ; Androgen Antagonists/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort.
Autorzy:
Shee K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Cowan JE; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Balakrishnan A; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Escobar D; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Chang K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Washington SL 3rd; Department of Urology, University of California-San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California-San Francisco, San Francisco, CA, USA.
Nguyen HG; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Shinohara K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Cooperberg MR; Department of Urology, University of California-San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California-San Francisco, San Francisco, CA, USA. Electronic address: .
Carroll PR; Department of Urology, University of California-San Francisco, San Francisco, CA, USA. Electronic address: .
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 9-12. Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*/diagnostic imaging
Prostate*/pathology
Prostatic Neoplasms*/pathology
Male ; Humans ; Watchful Waiting ; Retrospective Studies ; Biopsy ; Neoplasm Grading ; Prostate-Specific Antigen
Czasopismo naukowe
Szczegóły
Tytuł:
Incidence and predictors of urinary incontinence rates post-holmium laser enucleation of prostate.
Autorzy:
Elsaqa M; Baylor Scott & White Health, CTX, Temple, Texas, USA.; Alexandria University Faculty of Medicine, Alexandria, Egypt.
Zhang Y; Baylor Scott & White Health, CTX, Temple, Texas, USA.
Papaconstantinou H; Baylor Scott & White Health, CTX, Temple, Texas, USA.
Tayeb MME; Baylor Scott & White Health, CTX, Temple, Texas, USA.
Pokaż więcej
Źródło:
Lower urinary tract symptoms [Low Urin Tract Symptoms] 2023 Sep; Vol. 15 (5), pp. 185-190. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Frailty*/complications
Laser Therapy*/adverse effects
Lasers, Solid-State*/adverse effects
Prostatic Hyperplasia*/complications
Transurethral Resection of Prostate*/adverse effects
Urinary Incontinence*/etiology
Urinary Incontinence*/complications
Aged ; Humans ; Male ; Incidence ; Obesity/complications ; Prostate/surgery ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Early Endpoints in High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies.
Autorzy:
Feng F; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: .
Miladinovic B; Janssen Research & Development, San Diego, CA, USA.
Zhang K; Janssen Research & Development, San Diego, CA, USA.
Dignam JJ; The University of Chicago, Chicago, IL, USA.
Wang D; Janssen Research & Development, Los Angeles, CA, USA.
Yu M; Janssen Research & Development, Los Angeles, CA, USA.
Sandler H; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Sep; Vol. 84 (3), pp. 331-340. Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/pathology
Male ; Humans ; Androgen Antagonists/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prostate/pathology ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro.
Autorzy:
Kuzmanov A; Laboratory for Urologic Oncology and Stem Cell Therapy, Department of Urology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland.
Salemi S; Laboratory for Urologic Oncology and Stem Cell Therapy, Department of Urology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland.
Schmid FA; Laboratory for Urologic Oncology and Stem Cell Therapy, Department of Urology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.; Department of Nuclear Medicine, Baden Cantonal Hospital, 5404 Baden, Switzerland.
Eberli D; Laboratory for Urologic Oncology and Stem Cell Therapy, Department of Urology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland.
Kranzbühler B; Laboratory for Urologic Oncology and Stem Cell Therapy, Department of Urology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 02; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/pathology
Prostatic Neoplasms*/metabolism
Male ; Humans ; Dutasteride/pharmacology ; Dutasteride/metabolism ; Dutasteride/therapeutic use ; Lovastatin/pharmacology ; Glutamate Carboxypeptidase II/metabolism ; Antigens, Surface/metabolism ; Prostate-Specific Antigen/metabolism ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of holmium laser enucleation and transurethral resection of prostate in benign prostatic hyperplasia: a systematic review and meta-analysis.
Autorzy:
Chen F; Department of Urology, Shehong People's Hospital, Sichuan Province, China.
Chen Y; Department of Urology, Shehong People's Hospital, Sichuan Province, China.
Zou Y; Department of Urology, Shehong People's Hospital, Sichuan Province, China.
Wang Y; Department of Urology, Shehong People's Hospital, Sichuan Province, China.
Wu X; Department of Urology, Shehong People's Hospital, Sichuan Province, China.
Chen M; Department of Anesthesiology, Shehong People's Hospital, Sichuan Province, China.
Pokaż więcej
Źródło:
The Journal of international medical research [J Int Med Res] 2023 Aug; Vol. 51 (8), pp. 3000605231190763.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Transurethral Resection of Prostate*/adverse effects
Transurethral Resection of Prostate*/methods
Prostatic Hyperplasia*/surgery
Prostatic Hyperplasia*/etiology
Lasers, Solid-State*/therapeutic use
Laser Therapy*/adverse effects
Laser Therapy*/methods
Male ; Humans ; Prostate ; Holmium ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Anterior fibromuscular stroma-preserved endoscopic enucleation of the prostate: a precision anatomical approach.
Autorzy:
Lin YH; Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan. .; School of Medicine, Chang Gung University, Taoyuan 333, Taiwan. .
Chang SY; Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.
Tsao SH; Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.; School of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Hou CP; Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.; School of Medicine, Chang Gung University, Taoyuan 333, Taiwan.; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Chen CL; Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.; School of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Lin WC; Department of Urology, MacKay Memorial Hospital, Taipei 112, Taiwan.
Tsui KH; Department of Urology, Shuang Ho Hospital, Taipei Medical University, Taipei 112, Taiwan. .; TMU Research Center of Urology and Kidney (TMU-RCUK), Taipei Medical University, Taipei 112, Taiwan. .
Juang HH; Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan. .; Department of Anatomy, School of Medicine, Chang Gung University, Kwei-Shan, Taoyuan 333, Taiwan. .
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 Aug; Vol. 41 (8), pp. 2127-2132. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Laser Therapy*/methods
Prostatic Hyperplasia*/surgery
Transurethral Resection of Prostate*/methods
Urinary Incontinence*/surgery
Male ; Humans ; Prostate/surgery ; Retrospective Studies ; Treatment Outcome ; Endoscopy/methods ; Prostatectomy/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Intermediate Grade Prostate Cancer and Risk for Adverse Pathology Radical Prostatectomy: Implications for Partial Gland Ablation Case Selection.
Autorzy:
Stangl-Kremser J; Department of Urology, Weill Cornell Medicine, New York, NY.
Patel N; Department of Urology, Weill Cornell Medicine, New York, NY.
Hu JC; Department of Urology, Weill Cornell Medicine, New York, NY. Electronic address: .
Pokaż więcej
Źródło:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Aug; Vol. 21 (4), pp. 491-496. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/pathology
Prostatic Neoplasms*/pathology
Male ; Humans ; Neoplasm Grading ; Prostatectomy/adverse effects ; Prostate-Specific Antigen ; Biopsy
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-Utility Analysis of Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms.
Autorzy:
Capdevila F; Department of Pharmacy, University Hospital of Navarre (HUN), Calle Irunlarrea 3, 31008, Pamplona, Spain. .; Public University of Navarre (UPNA), Campus de Arrosadia, s/n, 31006, Pamplona, Spain. .; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, 31008, Pamplona, Spain. .
Insausti I; Department of Radiology, University Hospital of Navarre (HUN), Calle Irunlarrea 3, 31008, Pamplona, Spain.
San Miguel R; Department of Pharmacy, University Hospital of Navarre (HUN), Calle Irunlarrea 3, 31008, Pamplona, Spain.; Public University of Navarre (UPNA), Campus de Arrosadia, s/n, 31006, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, 31008, Pamplona, Spain.
Sanchez-Iriso E; Public University of Navarre (UPNA), Campus de Arrosadia, s/n, 31006, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, 31008, Pamplona, Spain.
Montesino M; Public University of Navarre (UPNA), Campus de Arrosadia, s/n, 31006, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, 31008, Pamplona, Spain.; Department of Urology, University Hospital of Navarre (HUN), Calle Irunlarrea 3, 31008, Pamplona, Spain.
Pokaż więcej
Źródło:
Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2023 Aug; Vol. 46 (8), pp. 1025-1035. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Prostatic Hyperplasia*/therapy
Prostatic Hyperplasia*/surgery
Embolization, Therapeutic*/methods
Transurethral Resection of Prostate*/methods
Lower Urinary Tract Symptoms*/therapy
Lower Urinary Tract Symptoms*/complications
Male ; Humans ; Prostate/blood supply ; Cost-Benefit Analysis ; Treatment Outcome ; Arteries
Czasopismo naukowe
Szczegóły
Tytuł:
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.
Autorzy:
Du X; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dong Y; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu J; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Su Y; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Zhu Y; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pan J; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dong B; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen R; Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu J; Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tong Z; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pienta KJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rowe SP; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dong L; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xue W; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
The Prostate [Prostate] 2023 Aug; Vol. 83 (11), pp. 1112-1120. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Male ; Humans ; Aged ; Prostate/pathology ; Positron Emission Tomography Computed Tomography/methods ; Neoadjuvant Therapy ; Retrospective Studies ; Gallium Radioisotopes ; Lymphatic Metastasis/pathology ; Prostatectomy
Czasopismo naukowe
Szczegóły
Tytuł:
Use of artificial intelligence in discerning the need for prostate biopsy and readiness for clinical practice: a systematic review protocol.
Autorzy:
Martinez-Marroquin E; Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, 2617, Australia. .
Chau M; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Canberra, ACT, 2617, Australia.
Turner M; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Canberra, ACT, 2617, Australia.
Haxhimolla H; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Canberra, ACT, 2617, Australia.
Paterson C; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Canberra, ACT, 2617, Australia.; Robert Gordon University, Aberdeen, AB10 7AQ, Scotland, UK.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2023 Jul 17; Vol. 12 (1), pp. 126. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*
Prostatic Neoplasms*/diagnosis
Male ; Humans ; Early Detection of Cancer ; Artificial Intelligence ; Prostate-Specific Antigen ; Biopsy/adverse effects ; Systematic Reviews as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 379520

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies